tagging recent news
Patent and Trademark
Leader v. Facebook to the U.S. Supreme Court?
May 8, 2012
COLUMBUS, Ohio, May 8, 2012 (SEND2PRESS NEWSWIRE) — Today a Federal court denied the appeal of Leader Technologies in the Leader v. Facebook patent infringement case. “This is suspiciously convenient timing for Facebook, coming hours after the Facebook roadshow commenced in New York,” said CEO Mike McKibben, referring to Facebook’s IPO kickoff yesterday.
According to McKibben, a lower court held that Facebook violated Leader’s patent on 11 of 11 claims, but then invalidated Leader’s patent by finding that Leader had tried to sell its technology too soon (“on-sale bar,” in legal parlance.)
“Leader asked the Federal Circuit to overrule this verdict, because the company’s patent interests were protected by a ‘no-reliance’ agreement that negated any possibility of making offers before we had signed contracts,” said McKibben. “But the court ignored these agreements, accepted Facebook-doctored evidence, and misquoted my testimony to justify their decision.”
“We are extremely disappointed,” McKibben added. “The appeals process is supposed to correct legal errors by juries, not simply root around for new evidence to justify not overturning a jury that was fooled by Facebook tricks.”
McKibben may appeal to the U.S. Supreme Court. “We firmly believe that the jury erred in their one finding against Leader,” he says. “Facebook is using our invention, as the jury agreed, without our permission. This court just condoned hacking of intellectual property and fabrication of evidence as acceptable business practices.”
The case is Leader Technologies Inc. v. Facebook Inc., 2011-1366, U.S. Court of Appeals for the Federal Circuit (Washington). The lower court case is Leader Technologies Inc. v. Facebook Inc., 08-cv-862, U.S. District Court, District of Delaware (Wilmington).
More information about Leader: http://www.leader.com .
News Source: Leader Technologies Incorporated :: This press release was issued on behalf of the news source by Send2Press® Newswire, a service of Neotrope®. View all current news at: http://Send2PressNewswire.com .
U.S. Patent Office Issues Sixth Patent Covering ‘Zero-Footprint’ Medical Image Viewers to Heart Imaging Technologies, LLC
May 1, 2012
DURHAM, N.C., May 1, 2012 (SEND2PRESS NEWSWIRE) — Heart IT, the global leader that pioneered the first FDA approved zero footprint medical imaging workstation, WebPAX®, announced today the award of its sixth patent covering “zero-footprint” medical image viewing technologies. “Zero-footprint” technologies allow health care professionals to view medical images using any computing platform with a standard Internet web browser.
This includes Microsoft’s Internet Explorer, Mozilla’s Firefox, Apple’s Safari, and Google’s Chrome on Windows-based desktop and laptop PCs in addition to Macintosh-based desktops and laptops. Further, WebPAX® enables users of mobile devices to access medical images through standard browsers on Apple’s iPad and iPhone, as well as all Google Android tablets and cell phones.
Without “zero-footprint” technologies, medical images can only be viewed by installing proprietary software that is different for each web browser, each operating system, and each hardware device.
U.S. Patent Number 8166381 issued on April 24, 2012. Heart IT’s “zero footprint” intellectual property portfolio also includes five previously-issued U.S. Patents: 6934698, 7457656, 7668835, 7958100, and 8055636. HeartIT’s intellectual property coverage for its issued patents extends through the year 2025. Additional related patents are pending review by the U.S. Patent and Trademark Office.
About Heart IT:
Founded in 2000 and headquartered near North Carolina’s Research Triangle Park, Heart IT is a global leader in the medical image web enablement field. Their flagship product, WebPAX®, was the world’s first FDA approved zero foot-print medical image workstation. It provides web-based medical image management technology and services to health care systems, large hospitals and private clinics as well as drug and device companies sponsoring multi-center clinical trials. Worldwide, WebPAX® systems currently provide secure web browser access to over one billion medical images. For more information visit our website at http://www.heartit.com .
“WebPAX” is a registered trademark of Heart Imaging Technologies, LLC. All other trademarks acknowledged.
News Source: Heart Imaging Technologies :: This press release was issued on behalf of the news source by Send2Press® Newswire, a service of Neotrope®. View all current news at: http://Send2PressNewswire.com .
